260 related articles for article (PubMed ID: 31638999)
1. Inhibition of the key metabolic pathways, glycolysis and lipogenesis, of oral cancer by bitter melon extract.
Sur S; Nakanishi H; Flaveny C; Ippolito JE; McHowat J; Ford DA; Ray RB
Cell Commun Signal; 2019 Oct; 17(1):131. PubMed ID: 31638999
[TBL] [Abstract][Full Text] [Related]
2. Bitter Melon Prevents the Development of 4-NQO-Induced Oral Squamous Cell Carcinoma in an Immunocompetent Mouse Model by Modulating Immune Signaling.
Sur S; Steele R; Aurora R; Varvares M; Schwetye KE; Ray RB
Cancer Prev Res (Phila); 2018 Apr; 11(4):191-202. PubMed ID: 29061560
[TBL] [Abstract][Full Text] [Related]
3. Bitter melon protects against ER stress in LS174T colonic epithelial cells.
Kunde DA; Chong WC; Nerurkar PV; Ahuja KD; Just J; Smith JA; Guven N; Eri RD
BMC Complement Altern Med; 2017 Jan; 17(1):2. PubMed ID: 28049460
[TBL] [Abstract][Full Text] [Related]
4. Bitter Melon (Momordica charantia) Extract Inhibits Tumorigenicity and Overcomes Cisplatin-Resistance in Ovarian Cancer Cells Through Targeting AMPK Signaling Cascade.
Yung MM; Ross FA; Hardie DG; Leung TH; Zhan J; Ngan HY; Chan DW
Integr Cancer Ther; 2016 Sep; 15(3):376-89. PubMed ID: 26487740
[TBL] [Abstract][Full Text] [Related]
5. Disrupting cholesterol esterification by bitter melon suppresses triple-negative breast cancer cell growth.
Shim SH; Sur S; Steele R; Albert CJ; Huang C; Ford DA; Ray RB
Mol Carcinog; 2018 Nov; 57(11):1599-1607. PubMed ID: 30074275
[TBL] [Abstract][Full Text] [Related]
6. Bitter melon (Momordica charantia) extract suppresses adrenocortical cancer cell proliferation through modulation of the apoptotic pathway, steroidogenesis, and insulin-like growth factor type 1 receptor/RAC-α serine/threonine-protein kinase signaling.
Brennan VC; Wang CM; Yang WH
J Med Food; 2012 Apr; 15(4):325-34. PubMed ID: 22191569
[TBL] [Abstract][Full Text] [Related]
7. Immunomodulatory role of bitter melon extract in inhibition of head and neck squamous cell carcinoma growth.
Bhattacharya S; Muhammad N; Steele R; Peng G; Ray RB
Oncotarget; 2016 May; 7(22):33202-9. PubMed ID: 27120805
[TBL] [Abstract][Full Text] [Related]
8. Bitter melon (Momordica charantia) extract inhibits breast cancer cell proliferation by modulating cell cycle regulatory genes and promotes apoptosis.
Ray RB; Raychoudhuri A; Steele R; Nerurkar P
Cancer Res; 2010 Mar; 70(5):1925-31. PubMed ID: 20179194
[TBL] [Abstract][Full Text] [Related]
9. Bitter Melon Extract Yields Multiple Effects on Intestinal Epithelial Cells and Likely Contributes to Anti-diabetic Functions.
Chang CI; Cheng SY; Nurlatifah AO; Sung WW; Tu JH; Lee LL; Cheng HL
Int J Med Sci; 2021; 18(8):1848-1856. PubMed ID: 33746602
[TBL] [Abstract][Full Text] [Related]
10. The Effect of Bitter Melon (Momordica charantia) Extract on the Uptake of
Kilcar AY; Yildiz O; Dogan T; Sulu E; Takan G; Muftuler FZB
Anticancer Agents Med Chem; 2020; 20(12):1497-1503. PubMed ID: 32329694
[TBL] [Abstract][Full Text] [Related]
11. MAP30 protein from Momordica charantia is therapeutic and has synergic activity with cisplatin against ovarian cancer in vivo by altering metabolism and inducing ferroptosis.
Chan DW; Yung MM; Chan YS; Xuan Y; Yang H; Xu D; Zhan JB; Chan KK; Ng TB; Ngan HY
Pharmacol Res; 2020 Nov; 161():105157. PubMed ID: 32814169
[TBL] [Abstract][Full Text] [Related]
12. Bitter melon extract impairs prostate cancer cell-cycle progression and delays prostatic intraepithelial neoplasia in TRAMP model.
Ru P; Steele R; Nerurkar PV; Phillips N; Ray RB
Cancer Prev Res (Phila); 2011 Dec; 4(12):2122-30. PubMed ID: 21911444
[TBL] [Abstract][Full Text] [Related]
13. Bitter melon derived extracellular vesicles enhance the therapeutic effects and reduce the drug resistance of 5-fluorouracil on oral squamous cell carcinoma.
Yang M; Luo Q; Chen X; Chen F
J Nanobiotechnology; 2021 Aug; 19(1):259. PubMed ID: 34454534
[TBL] [Abstract][Full Text] [Related]
14. Momordica charantia extract on insulin resistance and the skeletal muscle GLUT4 protein in fructose-fed rats.
Shih CC; Lin CH; Lin WL; Wu JB
J Ethnopharmacol; 2009 May; 123(1):82-90. PubMed ID: 19429344
[TBL] [Abstract][Full Text] [Related]
15. Bitter melon extract ameliorates palmitate-induced apoptosis via inhibition of endoplasmic reticulum stress in HepG2 cells and high-fat/high-fructose-diet-induced fatty liver.
Lee HJ; Cui R; Choi SE; Jeon JY; Kim HJ; Kim TH; Kang Y; Lee KW
Food Nutr Res; 2018; 62():. PubMed ID: 30026676
[TBL] [Abstract][Full Text] [Related]
16. Momordica charantia L. induces non-apoptotic cell death in human MDA-MB-436 breast and A549 lung cancer cells by disrupting energy metabolism and exacerbating reactive oxygen species' generation.
Ehigie AF; Wei P; Wei T; Yan X; Olorunsogo OO; Ojeniyi FD; Ehigie LO
J Ethnopharmacol; 2021 Sep; 277():114036. PubMed ID: 33753145
[TBL] [Abstract][Full Text] [Related]
17. Bitter Melon Enhances Natural Killer-Mediated Toxicity against Head and Neck Cancer Cells.
Bhattacharya S; Muhammad N; Steele R; Kornbluth J; Ray RB
Cancer Prev Res (Phila); 2017 Jun; 10(6):337-344. PubMed ID: 28465362
[TBL] [Abstract][Full Text] [Related]
18. Immunomodulatory Effects of
Rao CV
Cancer Prev Res (Phila); 2018 Apr; 11(4):185-186. PubMed ID: 29559516
[TBL] [Abstract][Full Text] [Related]
19. Pomegranate Seed Oil and Bitter Melon Extract Affect Fatty Acids Composition and Metabolism in Hepatic Tissue in Rats.
Stawarska A; Lepionka T; Białek A; Gawryjołek M; Bobrowska-Korczak B
Molecules; 2020 Nov; 25(22):. PubMed ID: 33182664
[TBL] [Abstract][Full Text] [Related]
20. Promise of bitter melon (Momordica charantia) bioactives in cancer prevention and therapy.
Raina K; Kumar D; Agarwal R
Semin Cancer Biol; 2016 Oct; 40-41():116-129. PubMed ID: 27452666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
